rs113488022, BRAF

N. diseases: 490
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 GeneticVariation BEFREE Accordingly, the combination of MEK inhibitor with EGFR inhibitor was effective at shrinking tumors in mouse model of BRAF non-V600E mutant lung cancer. 29348459 2018
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 GeneticVariation BEFREE Success of this design of clinical trials and practice was first demonstrated in EGFR inhibitor trials in lung cancer and has since been incorporated into subsequent targeted therapy trials including ALK-, ROS1-, and BRAF V600E-targeted therapies. 28786099 2017
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. 23833300 2013
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 GeneticVariation BEFREE BRAF V600E is an emerging drug target in lung cancer, but the clinical significance of non-V600 BRAF mutations in lung cancer and other malignancies is less clear. 24035431 2013
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer. 23524406 2013
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. 22608338 2012
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib. 22649091 2012
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. 22743296 2012
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1. 22773810 2012
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 GeneticVariation BEFREE The incidence of BRAF mutations other than V600E is significantly higher in lung cancer than in melanoma. 21483012 2011
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR The incidence of BRAF mutations other than V600E is significantly higher in lung cancer than in melanoma. 21483012 2011
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. 19238210 2009
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Genetic predictors of MEK dependence in non-small cell lung cancer. 19010912 2008
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 GeneticVariation BEFREE V599E BRAF mutation was uncommon in Japanese lung cancer. 16376942 2006
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Mutations of the BRAF gene in human cancer. 12068308 2002
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR Missense mutations of the BRAF gene in human lung adenocarcinoma. 12460919 2002
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
0.750 CausalMutation CLINVAR BRAF and RAS mutations in human lung cancer and melanoma. 12460918 2002